Endogenous adiponectin may function as a tumour suppressor gene through inhibiting the epithelial–mesenchymal transition of prostate cancer cells but is down-regulated in prostate cancer via promoter hypermethylation [59]. This evidence concerns the gene ADIPOQ and prostate carcinoma.